GLHRL

Global Longlife Hospital and Research financials

Market cap
₹14 Cr

Quarterly results

Q4 FY26: revenue down 100.0%, net profit up 87.6% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY23Q4 FY23Q2 FY24Q4 FY24Q2 FY25Q4 FY25Q2 FY26Q4 FY26
Revenue12 12 12 1 1 −95%0 −100%0 −100%0 −100%
EBITDA2 2 3 -3 -4 −315%-0 −115%-1 −122%-0 +87%
Net profit1 1 1 -3 1 +63%-1 −197%-1 −228%-0 +88%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −44.0% 1Y

₹10.0₹15.0₹20.0₹25.0Sept 25Oct 25Dec 25Jan 26Mar 26May 26Jun 26Aug 26

1Y: ₹25.09 on 3 Sept 2025 → ₹14.05. High ₹26 (22 Sept 2025), low ₹9.47 (9 Jul 2026).

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹7 Cr₹7 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr
Reserves₹7 Cr₹10 Cr₹54 Cr₹15 Cr₹15 Cr₹13 Cr
Borrowings₹17 Cr₹9 Cr₹9 Cr₹13 Cr₹0 Cr₹0 Cr
Other liabilities₹6 Cr₹8 Cr₹2 Cr₹3 Cr₹0 Cr₹0 Cr
Total liabilities₹37 Cr₹34 Cr₹76 Cr₹42 Cr₹25 Cr₹24 Cr
Fixed assets₹17 Cr₹17 Cr₹17 Cr₹17 Cr₹0 Cr₹0 Cr
Capital work in progress₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹19 Cr₹17 Cr₹58 Cr₹24 Cr₹25 Cr₹24 Cr
Total assets₹37 Cr₹34 Cr₹76 Cr₹42 Cr₹25 Cr₹24 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, promoters trimmed −32.02 pp while the public added +32.02 pp. The shareholder count grew 24% to 1,133.

Promoters
22.9%
Public
77.1%

Since Jun 2025

  • Promoters −32.02 pp
  • Public +32.02 pp

How it drifted, 12 quarters

Over this window promoters fell from 54.3% to 22.9% — −31.4 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 54.3%, Public 45.7%.Dec '23: Promoters 54.3%, Public 45.7%.Mar '24: Promoters 54.3%, Public 45.7%.Jun '24: Promoters 54.3%, Public 45.7%.Sep '24: Promoters 54.3%, Public 45.7%.Dec '24: Promoters 54.3%, Public 45.7%.Mar '25: Promoters 54.3%, Public 45.7%.Jun '25: Promoters 54.9%, Public 45.1%.Sep '25: Promoters 55.1%, Public 44.9%.Dec '25: Promoters 35.4%, Public 64.6%.Mar '26: Promoters 22.9%, Public 77.1%.Jun '26: Promoters 22.9%, Public 77.1%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 2 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Global Longlife Hospital and Research Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Dhruv Sureshkumar Jani 22.87%unchanged
Atrichhaya Financial Private Limited 3.24%+1.18 pp
L7 Hitech Private Limited 3.13%unchanged
Manish Upendra Shanghvi 2.52%unchanged
Jitendra Babulal Jain 2.38%unchanged
Yashwantlal Daxini 2.38%unchanged
Yogeshkumar Rasiklal Sanghavi 2.24%unchanged
Bakul Natwarlal Kotak 1.90%unchanged
Skyline Investments Private 1.62%+0.56 pp
Arpana Dinesh Lodha 1.30%unchanged
Mahesh Jain 1.29%unchanged
Everstock Markplex Private Limited 1.19%newly disclosed

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Global Longlife Hospital and Research Limited

Guides on how to read this kind of business and the numbers that matter.